Literature DB >> 34872976

Prosurvival IL-7-Stimulated Weak Strength of mTORC1-S6K Controls T Cell Memory via Transcriptional FOXO1-TCF1-Id3 and Metabolic AMPKα1-ULK1-ATG7 Pathways.

Aizhang Xu1,2, Scot C Leary3, Md Fahmid Islam1,2, Zhaojia Wu1,2, Kalpana Kalyanasundaram Bhanumathy1,2, Anjuman Ara1,2, Rajni Chibbar4, Andrew Fleywald4, Khawaja Ashfaque Ahmed5, Jim Xiang6,2.   

Abstract

CD8+ memory T (TM) cells play a critical role in immune defense against infection. Two common γ-chain family cytokines, IL-2 and IL-7, although triggering the same mTORC1-S6K pathway, distinctly induce effector T (TE) cells and TM cells, respectively, but the underlying mechanism(s) remains elusive. In this study, we generated IL-7R-/and AMPKα1-knockout (KO)/OTI mice. By using genetic and pharmaceutical tools, we demonstrate that IL-7 deficiency represses expression of FOXO1, TCF1, p-AMPKα1 (T172), and p-ULK1 (S555) and abolishes T cell memory differentiation in IL-7R KO T cells after Listeria monocytogenesis rLmOVA infection. IL-2- and IL-7-stimulated strong and weak S6K (IL-2/S6Kstrong and IL-7/S6Kweak) signals control short-lived IL-7R-CD62L-KLRG1+ TE and long-term IL-7R+CD62L+KLRG1- TM cell formations, respectively. To assess underlying molecular pathway(s), we performed flow cytometry, Western blotting, confocal microscopy, and Seahorse assay analyses by using the IL-7/S6Kweak-stimulated TM (IL-7/TM) and the control IL-2/S6Kstrong-stimulated TE (IL-2/TE) cells. We determine that the IL-7/S6Kweak signal activates transcriptional FOXO1, TCF1, and Id3 and metabolic p-AMPKα1, p-ULK1, and ATG7 molecules in IL-7/TM cells. IL-7/TM cells upregulate IL-7R and CD62L, promote mitochondria biogenesis and fatty acid oxidation metabolism, and show long-term cell survival and functional recall responses. Interestingly, AMPKα1 deficiency abolishes the AMPKα1 but maintains the FOXO1 pathway and induces a metabolic switch from fatty acid oxidation to glycolysis in AMPKα1 KO IL-7/TM cells, leading to loss of cell survival and recall responses. Taken together, our data demonstrate that IL-7-stimulated weak strength of mTORC1-S6K signaling controls T cell memory via activation of transcriptional FOXO1-TCF1-Id3 and metabolic AMPKα1-ULK1-ATG7 pathways. This (to our knowledge) novel finding provides a new mechanism for a distinct IL-2/IL-7 stimulation model in T cell memory and greatly impacts vaccine development.
Copyright © 2021 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34872976     DOI: 10.4049/jimmunol.2100452

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Distinct strengths of mTORC1 control T-cell memory via transcriptional FOXO1 and metabolic AMPKα1 pathways in linear cell differentiation and asymmetric cell division models.

Authors:  Junqiong Huang; Scot Leary; Jim Xiang
Journal:  Cell Mol Immunol       Date:  2022-05-19       Impact factor: 22.096

2.  Activation of Focal Adhesion Kinase Restores Simulated Microgravity-Induced Inhibition of Osteoblast Differentiation via Wnt/Β-Catenin Pathway.

Authors:  Cuihong Fan; Zhaojia Wu; David M L Cooper; Adam Magnus; Kim Harrison; B Frank Eames; Rajni Chibbar; Gary Groot; Junqiong Huang; Harald Genth; Jun Zhang; Xing Tan; Yulin Deng; Jim Xiang
Journal:  Int J Mol Sci       Date:  2022-05-17       Impact factor: 6.208

Review 3.  Signaling networks controlling ID and E protein activity in T cell differentiation and function.

Authors:  Sung-Min Hwang; Sin-Hyeog Im; Dipayan Rudra
Journal:  Front Immunol       Date:  2022-08-02       Impact factor: 8.786

4.  The Critical Role of AMPKα1 in Regulating Autophagy and Mitochondrial Respiration in IL-15-Stimulated mTORC1Weak Signal-Induced T Cell Memory: An Interplay between Yin (AMPKα1) and Yang (mTORC1) Energy Sensors in T Cell Differentiation.

Authors:  Anjuman Ara; Zhaojia Wu; Aizhang Xu; Khawaja Ashfaque Ahmed; Scot C Leary; Md Fahmid Islam; Rajni Chibbar; Yue Wu; Jim Xiang
Journal:  Int J Mol Sci       Date:  2022-08-23       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.